-transparent.png){kind=logo}
The antihypertensive effect and a non-invasive cardiovascular assessment of indapamide in patients with idiopathic hypertension have been investigated in an uncontrolled study. Indapamide was found to be an effective antihypertensive agent in a dose of 2.5 mg per day with a mean fall in blood pressure of 25/18 mmHg. Apart from the development of impotence in one patient, no side effects were encountered. Its effect on heart rate and cardiac output suggest that vasodilatation may contribute to its mode of action. Exercise performance is well maintained and cardiac performance appears to improve when blood pressure is lowered with this drug.
Related Publications
F G Dunn, and
W S Hillis, and
A Tweddel, and
A P Rae, and
A R Lorimer
July 1981,
The Medical journal of Australia,
F G Dunn, and
W S Hillis, and
A Tweddel, and
A P Rae, and
A R Lorimer
January 2007,
Kidney & blood pressure research,
F G Dunn, and
W S Hillis, and
A Tweddel, and
A P Rae, and
A R Lorimer
September 1997,
International journal of cardiology,
F G Dunn, and
W S Hillis, and
A Tweddel, and
A P Rae, and
A R Lorimer
March 2004,
Atherosclerosis,
F G Dunn, and
W S Hillis, and
A Tweddel, and
A P Rae, and
A R Lorimer
January 2006,
Kardiologiia,
F G Dunn, and
W S Hillis, and
A Tweddel, and
A P Rae, and
A R Lorimer
December 1982,
Minerva cardioangiologica,
F G Dunn, and
W S Hillis, and
A Tweddel, and
A P Rae, and
A R Lorimer
January 1998,
Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University,
F G Dunn, and
W S Hillis, and
A Tweddel, and
A P Rae, and
A R Lorimer
July 1983,
American heart journal,
F G Dunn, and
W S Hillis, and
A Tweddel, and
A P Rae, and
A R Lorimer
January 1988,
Arzneimittel-Forschung,
F G Dunn, and
W S Hillis, and
A Tweddel, and
A P Rae, and
A R Lorimer
February 2018,
Hepatology international,
